{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:08:35Z","timestamp":1777486115686,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jocn-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jocn.2017.06.003","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T14:15:13Z","timestamp":1499523313000},"page":"18-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Myelitis in systemic lupus erythematosus"],"prefix":"10.1016","volume":"44","author":[{"given":"Xiang-Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Bing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pearl","family":"Pai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2017.06.003_b0005","doi-asserted-by":"crossref","unstructured":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999, 42(4):599-608.","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F"},{"issue":"6524","key":"10.1016\/j.jocn.2017.06.003_b0010","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(48)90987-8","article-title":"Acute transverse myelitis complicating pneumonia; report of a case","volume":"2","author":"Suchett-Kaye","year":"1948","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.jocn.2017.06.003_b0015","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1212\/WNL.0b013e31823dc535","article-title":"Evidence-based guideline: clinical evaluation and treatment of transverse myelitis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"77","author":"Scott","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2017.06.003_b0020","doi-asserted-by":"crossref","unstructured":"Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002, 59(4):499-505.","DOI":"10.1212\/WNL.59.4.499"},{"issue":"4","key":"10.1016\/j.jocn.2017.06.003_b0025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.semarthrit.2008.10.007","article-title":"Understanding the epidemiology and progression of systemic lupus erythematosus","volume":"39","author":"Pons-Estel","year":"2010","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.jocn.2017.06.003_b0030","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V","article-title":"Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States","volume":"41","author":"Lawrence","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.jocn.2017.06.003_b0035","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/art.22641","article-title":"Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data","volume":"56","author":"Chakravarty","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jocn.2017.06.003_b0040","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1196\/annals.1422.013","article-title":"Systemic lupus erythematosus: the face of Asia","volume":"1108","author":"Feng","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.jocn.2017.06.003_b0045","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1191\/0961203306lu2305xx","article-title":"Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden","volume":"15","author":"Danchenko","year":"2006","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.jocn.2017.06.003_b0050","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0049-0172(99)80003-1","article-title":"Rheumatic diseases in North America's indigenous peoples","volume":"28","author":"Peschken","year":"1999","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.jocn.2017.06.003_b0055","first-page":"985","article-title":"Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies","volume":"30","author":"Sanna","year":"2003","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.jocn.2017.06.003_b0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0889-857X(21)00229-5","article-title":"Neuropsychiatric lupus","volume":"20","author":"West","year":"1994","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"10.1016\/j.jocn.2017.06.003_b0065","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.59.2.120","article-title":"Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature","volume":"59","author":"Kovacs","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.jocn.2017.06.003_b0070","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/rheumatology\/keu384","article-title":"Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus","volume":"54","author":"Bortoluzzi","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.jocn.2017.06.003_b0075","doi-asserted-by":"crossref","first-page":"e55843","DOI":"10.1371\/journal.pone.0055843","article-title":"Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients","volume":"8","author":"Kampylafka","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jocn.2017.06.003_b0080","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.nrl.0000149975.39201.0b","article-title":"Diagnosis and management of acute myelopathies","volume":"11","author":"Kaplin","year":"2005","journal-title":"Neurologist"},{"issue":"6","key":"10.1016\/j.jocn.2017.06.003_b0085","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-0404.2007.00835.x","article-title":"Nosology of idiopathic transverse myelitis syndromes","volume":"115","author":"Scott","year":"2007","journal-title":"Acta Neurol Scand"},{"issue":"11","key":"10.1016\/j.jocn.2017.06.003_b0090","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1002\/art.24937","article-title":"Distinct subtypes of myelitis in systemic lupus erythematosus","volume":"60","author":"Birnbaum","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.jocn.2017.06.003_b0095","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.jocn.2017.06.003_b0100","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/ard.51.4.550","article-title":"Cerebral occlusive vasculopathy in systemic lupus erythematosus and speculation on the part played by complement","volume":"51","author":"Hammad","year":"1992","journal-title":"Ann Rheum Dis"},{"issue":"1\u20132","key":"10.1016\/j.jocn.2017.06.003_b0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2009.05.003","article-title":"Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus","volume":"212","author":"Colasanti","year":"2009","journal-title":"J Neuroimmunol"},{"issue":"9","key":"10.1016\/j.jocn.2017.06.003_b0110","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1177\/0961203313496302","article-title":"Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus","volume":"22","author":"Vincent","year":"2013","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.jocn.2017.06.003_b0115","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar2484","article-title":"Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms","volume":"10","author":"George-Chandy","year":"2008","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.jocn.2017.06.003_b0120","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1177\/0961203309357061","article-title":"Intrathecal cytokine and chemokine profiling in neuropsychiatric lupus or lupus complicated with central nervous system infection","volume":"19","author":"Lu","year":"2010","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.jocn.2017.06.003_b0125","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/art.22451","article-title":"Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus","volume":"56","author":"Fragoso-Loyo","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.jocn.2017.06.003_b0130","doi-asserted-by":"crossref","first-page":"616","DOI":"10.7326\/0003-4819-83-5-616","article-title":"Transverse myelopathy in systemic lupus erythematosus. Report of three cases and review of the literature","volume":"83","author":"Andrianakos","year":"1975","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.jocn.2017.06.003_b0135","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/jnnp.55.9.830","article-title":"Lupus-related myelopathy: report of three cases and review of the literature","volume":"55","author":"Provenzale","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2017.06.003_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/14397595.2014.948535","article-title":"Transverse myelitis extended to disseminated encephalitis in systemic lupus erythematosus: Histological evidence for vasculitis","author":"Tono","year":"2014","journal-title":"Mod Rheumatol"},{"issue":"1\u20132","key":"10.1016\/j.jocn.2017.06.003_b0145","doi-asserted-by":"crossref","first-page":"67","DOI":"10.20452\/pamw.608","article-title":"Myelitis in the course of systemic lupus erythematosus: review","volume":"119","author":"Lukjanowicz","year":"2009","journal-title":"Pol Arch Med Wewn"},{"issue":"3","key":"10.1016\/j.jocn.2017.06.003_b0150","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ana.20770","article-title":"Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis","volume":"59","author":"Weinshenker","year":"2006","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1016\/j.jocn.2017.06.003_b0155","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1177\/0961203314541690","article-title":"Myelitis in systemic lupus erythematosus frequently manifests as longitudinal and sometimes occurs at low disease activity","volume":"23","author":"Li","year":"2014","journal-title":"Lupus"},{"issue":"12","key":"10.1016\/j.jocn.2017.06.003_b0160","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/ard.59.12.936","article-title":"EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)","volume":"59","author":"Pendleton","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.jocn.2017.06.003_b0165","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.semarthrit.2008.09.002","article-title":"Transverse myelitis affecting more than 4 spinal segments associated with systemic lupus erythematosus: clinical, immunological, and radiological characteristics of 22 patients","volume":"39","author":"Espinosa","year":"2010","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jocn.2017.06.003_b0170","first-page":"34","article-title":"Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies","volume":"17","author":"Lavalle","year":"1990","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.jocn.2017.06.003_b0175","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00005792-198911000-00003","article-title":"Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients","volume":"68","author":"Alarcon-Segovia","year":"1989","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.jocn.2017.06.003_b0180","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/0961203314547795","article-title":"Systemic lupus erythematosus-associated acute transverse myelitis: manifestations, treatments, outcomes, and prognostic factors in 20 patients","volume":"24","author":"Saison","year":"2015","journal-title":"Lupus"},{"issue":"8","key":"10.1016\/j.jocn.2017.06.003_b0185","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.jocn.2017.06.003_b0190","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jocn.2017.06.003_b0195","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0961203313512883","article-title":"The American College of Rheumatology and the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus in two multiethnic cohorts: a commentary","volume":"23","author":"Pons-Estel","year":"2014","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.jocn.2017.06.003_b0200","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.semarthrit.2013.11.007","article-title":"Coexistence of systemic lupus erythematosus and multiple sclerosis: prevalence, clinical characteristics, and natural history","volume":"43","author":"Fanouriakis","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jocn.2017.06.003_b0205","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1352458511431077","article-title":"The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease","volume":"18","author":"Wingerchuk","year":"2012","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.jocn.2017.06.003_b0210","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jocn.2017.06.003_b0215","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/jmri.24563","article-title":"MRI in transverse myelitis","volume":"40","author":"Goh","year":"2014","journal-title":"J Magn Reson Imaging"},{"issue":"11","key":"10.1016\/j.jocn.2017.06.003_b0220","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","article-title":"MRI characteristics of neuromyelitis optica spectrum disorder: an international update","volume":"84","author":"Kim","year":"2015","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jocn.2017.06.003_b0225","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/0961203307079502","article-title":"High dose methylprednisolone therapy for the treatment of severe systemic lupus erythematosus","volume":"16","author":"Parker","year":"2007","journal-title":"Lupus"},{"issue":"19","key":"10.1016\/j.jocn.2017.06.003_b0230","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1212\/01.wnl.0000260970.63493.c8","article-title":"Idiopathic transverse myelitis: corticosteroids, plasma exchange, or cyclophosphamide","volume":"68","author":"Greenberg","year":"2007","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jocn.2017.06.003_b0235","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2004.025528","article-title":"Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus","volume":"64","author":"Barile-Fabris","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.jocn.2017.06.003_b0240","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/ard.2010.130476","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs","volume":"69","author":"Bertsias","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.jocn.2017.06.003_b0245","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1526-0968.2003.00032.x","article-title":"The role of plasmapheresis in the treatment of severe central nervous system neuropsychiatric systemic lupus erythematosus","volume":"7","author":"Neuwelt","year":"2003","journal-title":"Ther Apher Dial"},{"issue":"4","key":"10.1016\/j.jocn.2017.06.003_b0250","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/0961203307088005","article-title":"Prognostic factors of lupus myelopathy","volume":"17","author":"Lu","year":"2008","journal-title":"Lupus"},{"issue":"12","key":"10.1016\/j.jocn.2017.06.003_b0255","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1191\/096120301701548490","article-title":"Longitudinal myelitis associated with systemic lupus erythematosus: clinical features and magnetic resonance imaging of six cases","volume":"10","author":"Tellez-Zenteno","year":"2001","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/j.jocn.2017.06.003_b0260","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s10067-011-1714-5","article-title":"Rituximab in the treatment of severe lupus myelopathy","volume":"30","author":"Ye","year":"2011","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.jocn.2017.06.003_b0265","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/ard.2006.057885","article-title":"Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system","volume":"66","author":"Tokunaga","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.jocn.2017.06.003_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-013-7169-7","article-title":"Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS)","volume":"261","author":"Trebst","year":"2014","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.jocn.2017.06.003_b0275","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1468-1331.2010.03208.x","article-title":"Acute transverse myelitis and antiphospholipid antibodies in lupus. No evidence for anticoagulation","volume":"18","author":"Katsiari","year":"2011","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.jocn.2017.06.003_b0280","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/ard.2007.070367","article-title":"EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics","volume":"67","author":"Bertsias","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.jocn.2017.06.003_b0285","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1007\/s00296-011-2053-1","article-title":"Initial presentation of acute transverse myelitis in systemic lupus erythematosus: demographics, diagnosis, management and comparison to idiopathic cases","volume":"32","author":"Schulz","year":"2012","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.jocn.2017.06.003_b0290","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0003-9993(98)90150-2","article-title":"Three women with lupus transverse myelitis: case reports and differential diagnosis","volume":"79","author":"Inslicht","year":"1998","journal-title":"Arch Phys Med Rehabil"},{"issue":"2","key":"10.1016\/j.jocn.2017.06.003_b0295","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/ard.48.2.160","article-title":"Transverse myelitis occurring during pregnancy in a patient with systemic lupus erythematosus","volume":"48","author":"Marabani","year":"1989","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.jocn.2017.06.003_b0300","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.amjmed.2003.09.042","article-title":"Longitudinal myelitis in a pregnant patient with SLE","volume":"116","author":"Moranne","year":"2004","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.jocn.2017.06.003_b0305","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/archneurol.2009.194","article-title":"Nineteen episodes of recurrent myelitis in a woman with neuromyelitis optica and systemic lupus erythematosus","volume":"66","author":"Nasir","year":"2009","journal-title":"Arch Neurol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586817304058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586817304058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T17:12:54Z","timestamp":1750525974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586817304058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":61,"alternative-id":["S0967586817304058"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2017.06.003","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myelitis in systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2017.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}